TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

57.90$ -6.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MBX
Line item 2022 2023 2024 2025
+180.4% +55.4% -1,579.9%
+567.6% +155.6% +66.2%
-157.0% -65.7%
-70.7% +577.5% +120.7%
+171.0% +419.3% -47.9%
-100.0%
+50.3% +238.2% -19.0%
-45.2% +198.2% +37.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?